Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
International Business Development. Hill brings strong operational insight into the nuances and challenges of a wide range of clinical studies – from cutting-edge early phase gene therapy to real-world evidence and patient registries – along with ...
read more
Microbiotica has entered into a multi-year strategic collaboration with Genentech to discover, develop and commercialize biomarkers, targets and medicines for inflammatory bowel disease.
read more
Hi-Tech Pharmaceuticals has received third-party independent GMP certification of its Georgia and Pennsylvania facilities.
read more
Dalton Pharma Services has successfully received a ‘Compliant’ rating from the Health Products and Food Branch Inspectorate of Health Canada.
read more
AMRI has secured a seven-year contract from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH).
read more
Crown Bioscience announced the appointment of Laurie Heilmann as President of CrownBio Global Life Science Product and Diagnostic Solutions.
read more
Paragon Bioservices has appointed Gerard Fleury as Chief Financial Officer.
read more
BioMarin announced that the company received $20 million in milestone payments from Pfizer.
read more
PCI Pharma Services has announced the promotion of Brian Keesee to the new position of Vice President and General Manager, Global Clinical Operations and Supply.
read more
The Wasdell Group is investing £500k in a new laboratory at its Newcastle site.
read more
Alexion Pharmaceuticals and Complement Pharma announced a partnership to co-develop the preclinical C6 complement inhibitor CP010 for neurodegenerative disorders.
read more
AMRI has announced the appointment of Prakash Pandian as chief information officer.
read more
Fresenius Medical Care and Humacyte announced a strategic, global partnership and a $150M USD equity investment.
read more
According to the complaint, despite Delta Pharma’s repeated promises to correct deficiencies, Delta Pharma continued to violate the law.
read more
PharmaMar has announced today the signing of a commercialization and distribution license agreement with Pint Pharma International for the marine-derived anticancer drug Aplidin.
read more